Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 11, 2026 19:43 ET | Source: The Rosen Law Firm PA

ROSEN, A LONGSTANDING LAW FIRM, Encourages Dun & Bradstreet Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DNB

NEW YORK, Oct. 12, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds persons or entities that: (a) sold shares of Dun & Bradstreet Holdings, Inc. (NYSE:...
October 11, 2026 19:27 ET | Source: The Rosen Law Firm PA

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - UNCY

NEW YORK, Oct. 11, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Unicycive Therapeutics, Inc. (NASDAQ: UNCY) between December...
October 11, 2026 19:00 ET | Source: The Rosen Law Firm PA

AARD 截止日期通知：知名律師事務所 ROSEN 提醒 Aardvark Therapeutics, Inc. 投資人，應於證券集體訴訟重要期限 10 月 13 日之前委任法律律師 – AARD

紐約, Oct. 12, 2026 (GLOBE NEWSWIRE) -- 事由：全球投資人權益律師事務所 Rosen Law Firm 提醒 Aardvark Therapeutics, Inc. (NASDAQ: AARD) 的下列證券購買人，應注意 2026 年 10 月 13 日的重要首席原告提名期限：(i) 依據 Aardvark 於 2025 年 2 月 13...
October 11, 2026 19:00 ET | Source: The Rosen Law Firm PA

AARD DEADLINE NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Aardvark Therapeutics, Inc. Investors to Secure Counsel Before Important October 13 Deadline in Securities Class Action – AARD

NEW YORK, Oct. 11, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Aardvark Therapeutics, Inc. (NASDAQ: AARD): (i) common stock pursuant...
October 11, 2026 18:06 ET | Source: The Rosen Law Firm PA

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages FuelCell Energy, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FCEL

NEW YORK, Oct. 11, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities FuelCell Energy, Inc. (NASDAQ: FCEL) between June 24, 2026 and...
October 11, 2026 17:30 ET | Source: Remittix

New Crypto: Remittix Confirms November 24 RTX Launch as Ethereum Price Prediction Eyes $12,000 and Cardano’s Tokenized-Equity Push Revives the $1 ADA Dream

MAJURO, Marshall Islands, Oct. 11, 2026 (GLOBE NEWSWIRE) -- Remittix has confirmed November 24, 2026 as the scheduled market-launch date for RTX, placing a defined deadline on the final phase of a...
October 11, 2026 17:10 ET | Source: Robbins Geller Rudman & Dowd LLP

INVESTOR ALERT: Webull Corporation Investors with Substantial Losses May Seek to Lead Class Action Lawsuit Before December 7, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces - BULL

The case alleges Webull and its top executives made false and/or misleading statements to investors.
October 11, 2026 17:03 ET | Source: Bronstein, Gewirtz & Grossman, LLC

Bronstein, Gewirtz & Grossman LLC Urges Netcapital Inc. Investors to Act: Class Action Filed Alleging Investor Harm

New class action for Netcapital (NCPL) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 12/7/2026
October 11, 2026 16:00 ET | Source: First Tracks Biotherapeutics Inc

First Tracks Biotherapeutics to Announce Top-Line Data from Cohort 1 of Phase 1b Trial of ANB033, a CD122 antagonist, in Celiac Disease on Oct. 12, 2026

SAN DIEGO, Oct. 11, 2026 (GLOBE NEWSWIRE) -- First Tracks Biotherapeutics, Inc. (Nasdaq: TRAX), a clinical-stage biotechnology company advancing antibody therapeutics that modulate immune pathways...
October 11, 2026 14:30 ET | Source: BridgeBio Pharma, Inc.

Acoramidis Associated with Significantly Improved Clinical Outcomes Versus Tafamidis in ATTR-CM in an Independent, Real-World Study of U.S. Electronic Health Records

- In an independent, propensity score-matched analysis of 2,684 individuals living with ATTR-CM from Epic COSMOS, the largest U.S. electronic health record database, acoramidis was associated with a...